Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Louie, Michael K
CLEAR Path 1, NCT05694260 / 2018-004084-31: A Phase 2 Clinical Study in Children With HeFH Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing	Recruiting	2	54	Europe, Canada, US	Bempedoic acid, ETC-1002	Esperion Therapeutics, Inc., Esperion Therapeutics, Inc.	Hypercholesterolemia	03/24	05/24
NCT05103254: Bempedoic Acid Pregnancy Surveillance Program	Recruiting	N/A	20	US	Bempedoic Acid, Nexletol, Bempedoic Acid / Ezetimibe, Nexlizet	Esperion Therapeutics, Inc.	Pregnancy, Hyperlipidemias	05/32	05/32